Wedmont Private Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WCG
FWCM
BRCM
IWA
NRS
ACM
GI
FFA
PCA
WF
Wedmont Private Capital's EW Position: Q3 2026 in Review
Wedmont Private Capital increased its Edwards Lifesciences (EW) stake by 3.4% in Q3 2026, buying an estimated $39.5K and bringing the position to 13,513 shares worth $1.14M. The position accounts for 0.03% of the portfolio, ranked #351.
Wedmont Private Capital first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.21M in Q2 2026. 47 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Wedmont Private Capital held 13,513 shares of Edwards Lifesciences worth $1.14M as of Q3 2026.
- Wedmont Private Capital bought 444 Edwards Lifesciences shares in Q3 2026, an estimated $39.5K.
- Edwards Lifesciences made up 0.03% of Wedmont Private Capital's portfolio in Q3 2026, its #351 holding.
- Wedmont Private Capital first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
- Wedmont Private Capital's Edwards Lifesciences position peaked at $1.21M in Q2 2026.
- 47 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.